Dr. Andreas Bender is the Chief Technology & Informatics Officer at PangeAI and a Professor for Molecular Informatics at Cambridge University. His research focuses on using data analysis, machine learning, and AI techniques for drug selection and design, and he has published extensively in this area. He has held various roles in the pharmaceutical industry and has been involved in setting up data-driven drug repurposing and novel chemistry design companies.